Nika Pharmaceuticals, Inc. (NIKA) Signed a Distribution Agreement for Nigeria
18 juil. 2024 11h35 HE
|
Nika Pharmaceuticals, Inc.
Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA) signed a distribution agreement for the Republic of Nigeria that can generate the company €7.9 billion revenue.
Nika Pharmaceuticals, Inc. (NIKA) Presents Its Business Strategy
03 juin 2024 10h35 HE
|
Nika Pharmaceuticals, Inc.
Nika Pharmaceuticals, Inc. (NIKA) introduces its business strategy that should generate a net profit of more than 1 billion USD by the end of 2025.
Nika Pharmaceuticals, Inc. (NIKA) Acquires a Two Million USD Production Building
10 mai 2024 13h41 HE
|
Nika Pharmaceuticals, Inc.
Nika Pharmaceuticals, Inc. (NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production line.
Nika Pharmaceuticals, Inc. (Nika) Acquires a Two Million USD Production Building
10 mai 2024 12h55 HE
|
Nika Pharmaceuticals, Inc.
Nika Pharmaceuticals, Inc. (NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production line.
Nika Pharmaceuticals, Inc. (NKPH) Purchased the Technologies for Three Drugs in Tablet Form and One Dietary Supplement
15 avr. 2024 09h48 HE
|
Nika Pharmaceuticals, Inc.
Nika Pharmaceuticals, Inc. (NKPH) announces the purchase of technologies for production of three generic drugs in tablet form and one dietary supplement.
Nika Pharmaceuticals, Inc. (NKPH) Merges With Nika Biotechnology, Inc.
20 mars 2024 14h30 HE
|
Nika Pharmaceuticals, Inc.
Nika Pharmaceuticals, Inc. (OTCMKTS: NKPH) announces its merger with Nika BioTechnology, Inc., effective as of March 1, 2024.